Michigan HB5204 prohibits insurers from requiring patients with advanced metastatic cancer to fail a different drug before covering their current.
Michigan HB5204 amends the state's insurance laws to ensure that health insurers cannot require patients with advanced metastatic cancer to fail a different prescription drug or prove a history of failure with another drug before covering their current prescription. This applies to health insurance policies that provide coverage for prescription drugs for advanced metastatic cancer and associated conditions.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.